Top News
Latest News
INVESTMENT
6 Apr 2026
RNA Gets a $2.4B Promotion at Eli LillyPARTNERSHIPS
31 Mar 2026
RNA Meets Cell Therapy, and Texas Is Holding the HandshakeREGULATORY
26 Mar 2026
No Trial? No Problem. FDA Rewrites the RNA RulesINVESTMENT
23 Mar 2026
New Funding Backs Precision in mRNA Medicine
Fatty Bubbles and the $2.25 Billion Peace
PARTNERSHIPS
17 Mar 2026
Moderna settles landmark LNP patent dispute for up to $2.25B, securing a royalty-free delivery license for its infectious disease vaccine programs
INNOVATION
6 Mar 2026
Beta Cells Get a New Line of Defense
UChicago scientists use LNP-mRNA to protect insulin-producing cells from immune attack in type 1 diabetes
TECHNOLOGY
4 Mar 2026
The Tiny Carriers Powering mRNA’s Next Leap
A next-generation nanoparticle may make repeat mRNA dosing possible, transforming treatments for chronic diseases
INSIGHTS
2 Mar 2026
A Single Jab for Flu and COVID? EU Says Yes
EU advisers back Moderna’s combo flu and COVID vaccine, setting up a pivotal decision that could reshape seasonal immunization
INNOVATION
25 Feb 2026
Layered Nanoparticles Boost mRNA Delivery
Core-shell lipid nanoparticles show early gains in mRNA release but raise new design and safety questions
PARTNERSHIPS
24 Feb 2026
Can Smarter Nanoparticles Unlock RNA’s Next Wave?
The partners aim to improve LNP stability and targeting as demand rises for scalable, next-generation RNA platforms
INVESTMENT
23 Feb 2026
A £1B Shot in the Arm for UK Vaccine Power
A £1B investment anchors UK mRNA production, with capacity for 100M doses and rapid emergency expansion
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.